Caspase-8 as a therapeutic target in cancer

Cancer Letters

Volumn 332, Issue 2, 2013, Pages 133-140

  Stupack, Dwayne G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Cell migration; Death receptor; Metastasis; Non apoptotic; Programmed cell death; Tumor

Indexed keywords

AZACITIDINE; BORTEZOMIB; CASPASE 8; COLCHICINE; DEATH RECEPTOR; GAMMA INTERFERON; RETINOIC ACID; SALINOSPORAMIDE A; TAXANE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESEARCH; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; CASPASE 8; CELL ADHESION; CELL MOVEMENT; ENDOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NF-KAPPA B;

EID: 84876087841     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.07.022     Document Type: Article

References (76)

1. Garcia-Calvo M., Peterson E.P., Leiting B., Ruel R., Nicholson D.W., Thornberry N.A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 1998, 273:32608-32613.
2. Rozman-Pungercar J., Kopitar-Jerala N., Bogyo M., Turk D., Vasiljeva O., Stefe I., Vandenabeele P., Bromme D., Puizdar V., Fonovic M., Trstenjak-Prebanda M., Dolenc I., Turk V., Turk B. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ. 2003, 10:881-888.
3. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M., Ricci J.E., Edris W.A., Sutherlin D.P., Green D.R., Salvesen G.S. A unified model for apical caspase activation. Mol. Cell 2003, 11:529-541.
4. Pop C., Fitzgerald P., Green D.R., Salvesen G.S. Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 2007, 46:4398-4407.
5. Oberst A., Pop C., Tremblay A.G., Blais V., Denault J.B., Salvesen G.S., Green D.R. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J. Biol. Chem. 2010.
6. Blanchard H., Donepudi M., Tschopp M., Kodandapani L., Wu J.C., Grutter M.G. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex. J. Mol. Biol. 2000, 302:9-16.
7. N. Keller, M.G. Grutter, O. Zerbe, Studies of the molecular mechanism of caspase-8 activation by solution NMR, Cell Death Differ., 2009.
8. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 1998, 273:2926-2930.
9. Stupack D.G., Puente X.S., Boutsaboualoy S., Storgard C.M., Cheresh D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 2001, 155:459-470.
10. Boatright K.M., Deis C., Denault J.B., Sutherlin D.P., Salvesen G.S. Activation of caspases-8 and -10 by FLIP(L). Biochem. J. 2004, 382:651-657.
11. Scaffidi C., Medema J.P., Krammer P.H., Peter M.E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem. 1997, 272:26953-26958.
12. Eckhart L., Ballaun C., Hermann M., VandeBerg J.L., Sipos W., Uthman A., Fischer H., Tschachler E. Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire. Mol. Biol. Evol. 2008, 25:831-841.
13. Chun H.J., Zheng L., Ahmad M., Wang J., Speirs C.K., Siegel R.M., Dale J.K., Puck J., Davis J., Hall C.G., Skoda-Smith S., Atkinson T.P., Straus S.E., Lenardo M.J. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002, 419:395-399.
14. Himeji D., Horiuchi T., Tsukamoto H., Hayashi K., Watanabe T., Harada M. Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. Blood 2002, 99:4070-4078.
15. Miller M.A., Karacay B., Zhu X., O'Dorisio M.S., Sandler A.D. Caspase 8L, a novel inhibitory isoform of caspase 8, is associated with undifferentiated neuroblastoma. Apoptosis 2006, 11:15-24.
16. Tsukumo S.I., Yonehara S. Requirement of cooperative functions of two repeated death effector domains in caspase-8 and in MC159 for induction and inhibition of apoptosis, respectively. Genes Cells 1999, 4:541-549.
17. Mielgo A., Torres V.A., Clair K., Barbero S., Stupack D.G. Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene 2009, 28:3551-3562.
18. McDonald E.R., El-Deiry W.S. Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc. Natl. Acad. Sci. USA 2004, 101:6170-6175.
19. Siegel R.M., Martin D.A., Zheng L., Ng S.Y., Bertin J., Cohen J., Lenardo M.J. Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J. Cell Biol. 1998, 141:1243-1253.
20. A. Mielgo, V.A. Torres, M.C. Schmid, R. Graf, S. Zeitlin, P. Lee, D.J. Shields, S. Barbero, C. Jamora, D.G. Stupack, The death effector domains of caspase-8 induce terminal differentiation. PLoS ONE, 2009.
21. Medema J.P., Scaffidi C., Kischkel F.C., Shevchenko A., Mann M., Krammer P.H., Peter M.E. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). Embo J. 1997, 16:2794-2804.
22. Park H.H., Lo Y.C., Lin S.C., Wang L., Yang J.K., Wu H. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 2007, 25:561-586.
23. Mahmood Z., Shukla Y. Death receptors: targets for cancer therapy. Exp. Cell Res. 2010, 316:887-899.
24. Feng G., Kaplowitz N. Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. J. Clin. Invest. 2000, 105:329-339.
25. Hoogwater F.J.H., et al. Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells. Gastroenterology 2010, 138:2357-2367.
26. Lejeune F.J., Ruegg C. Recombinant human tumor necrosis factor: an efficient agent for cancer treatment. Bull. Cancer 2006, 93:E90-100.
27. Bellail A.C., Qi L., Mulligan P., Chhabra V., Hao C. TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev. Rec. Clin. Trials 2009, 4:34-41.
28. Kang T.B., Ben-Moshe T., Varfolomeev E.E., Pewzner-Jung Y., Yogev N., Jurewicz A., Waisman A., Brenner O., Haffner R., Gustafsson E., Ramakrishnan P., Lapidot T., Wallach D. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 2004, 173:2976-2984.
29. Barnhart B.C., Legembre P., Pietras E., Bubici C., Franzoso G., Peter M.E. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. Embo J. 2004, 23:3175-3185.
30. Chen L., Park S.M., Tumanov A.V., Hau A., Sawada K., Feig C., Turner J.R., Fu Y.X., Romero I.L., Lengyel E., Peter M.E. CD95 promotes tumour growth. Nature 2010, 465:492-496.
31. Kim H.S., Lee J.W., Soung Y.H., Park W.S., Kim S.Y., Lee J.H., Park J.Y., Cho Y.G., Kim C.J., Jeong S.W., Nam S.W., Kim S.H., Lee J.Y., Yoo N.J., Lee S.H. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003, 125:708-715.
32. Soung Y.H., Lee J.W., Kim S.Y., Jang J., Park Y.G., Park W.S., Nam S.W., Lee J.Y., Yoo N.J., Lee S.H. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res. 2005, 65:815-821.
33. Lubahn J., Berndt S.I., Jin C.H., Klim A., Luly J., Wu W.S., Isaacs S., Wiley K., Isaacs W.B., Suarez B.K., Hayes R.B., Kibel A.S. Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate 2010, 70:646-653.
34. MacPherson G., Healey C.S., Teare M.D., Balasubramanian S.P., Reed M.W., Pharoah P.D., Ponder B.A., Meuth M., Bhattacharyya N.P., Cox A. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl. Cancer Inst. 2004, 96:1866-1869.
35. Iwase M., Takaoka S., Uchida M., Yoshiba S., Kondo G., Watanabe H., Ohashi M., Nagumo M. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells. Oral. Oncol. 2008, 44:361-368.
36. Keller N., Mares J., Zerbe O., Grutter M.G. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation. Structure 2009, 17:438-448.
37. Cursi S., Rufini A., Stagni V., Condo I., Matafora V., Bachi A., Bonifazi A.P., Coppola L., Superti-Furga G., Testi R., Barila D. Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. Embo J. 2006, 25:1895-1905.
38. Hopkins-Donaldson S., Bodmer J.L., Bourloud K.B., Brognara C.B., Tschopp J., Gross N. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 2000, 60:4315-4319.
39. Teitz T., Lahti J.M., Kidd V.J. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J. Mol. Med. 2001, 79:428-436.
40. Grotzer M.A., Eggert A., Zuzak T.J., Janss A.J., Marwaha S., Wiewrodt B.R., Ikegaki N., Brodeur G.M., Phillips P.C. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 2000, 19:4604-4610.
41. Shivapurkar N., Toyooka S., Eby M.T., Huang C.X., Sathyanarayana U.G., Cunningham H.T., Reddy J.L., Brambilla E., Takahashi T., Minna J.D., Chaudhary P.M., Gazdar A.F. Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther. 2002, 1:65-69.
42. Ebinger M., Senf L., Wachowski O., Scheurlen W. Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma. Pathol. Oncol. Res. 2004, 10:17-21.
43. Martinez R., Setien F., Voelter C., Casado S., Quesada M.P., Schackert G., Esteller M. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 2007, 28:1264-1268.
44. Su H., Bidere N., Zheng L., Cubre A., Sakai K., Dale J., Salmena L., Hakem R., Straus S., Lenardo M. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005, 307:1465-1468.
45. Ponten F., Jirstrom K., Uhlen M. The human protein atlas-a tool for pathology. J. Pathol. 2008, 216:387-393.
46. Zhang X., Graham S.H., Kochanek P.M., Marion D.W., Nathaniel P.D., Watkins S.C., Clark R.S. Caspase-8 expression and proteolysis in human brain after severe head injury. Faseb J. 2003, 17:1367-1369.
47. Gdynia G., Grund K., Eckert A., Bock B.C., Funke B., Macher-Goeppinger S., Sieber S., Herold-Mende C., Wiestler B., Wiestler O.D., Roth W. Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Mol. Cancer Res. 2007, 5:1232-1240.
48. Stupack D.G., Teitz T., Potter M.D., Mikolon D., Houghton P.J., Kidd V.J., Lahti J.M., Cheresh D.A. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006, 439:95-99.
49. Krelin Y., Zhang L., Kang T.B., Appel E., Kovalenko A., Wallach D. Caspase-8 deficiency facilitates cellular transformation in vitro. Cell Death Differ. 2008, 15:1350-1355.
50. Reddig P.J., Juliano R.L. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metast. Rev. 2005, 24:425-439.
51. Muhlethaler-Mottet A., Bourloud K.B., Auderset K., Joseph J.M., Gross N. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Oncogene 2004, 23:5415-5425.
52. Nimmanapalli R., Perkins C.L., Orlando M., O'Bryan E., Nguyen D., Bhalla K.N. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res. 2001, 61:759-763.
53. Chen C., Liu Y., Zheng D. An agonistic monoclonal antibody against DR5 induces ROS production, sustained JNK activation and Endo G release in Jurkat leukemia cells. Cell Res. 2009, 19:984-995.
54. Ling Y.H., Lin R., Perez-Soler R. Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK. Mol. Pharmacol. 2008, 74:793-806.
55. Zhang H., Xu Q., Krajewski S., Krajewska M., Xie Z., Fuess S., Kitada S., Pawlowski K., Godzik A., Reed J.C. BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc. Natl. Acad. Sci. USA 2000, 97:2597-2602.
56. Stegh A.H., Barnhart B.C., Volkland J., Algeciras-Schimnich A., Ke N., Reed J.C., Peter M.E. Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein. J. Biol. Chem. 2002, 277:4351-4360.
57. Kelleher Z.T., Matsumoto A., Stamler J.S., Marshall H.E. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J. Biol. Chem. 2007, 282:30667-30672.
58. Bubici C., Papa S., Pham C.G., Zazzeroni F., Franzoso G. NF-kappaB and JNK: an intricate affair. Cell Cycle 2004, 3:1524-1529.
59. Thorpe J.A., Christian P.A., Schwarze S.R. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis. Prostate 2008, 68:200-209.
60. Voortman J., Resende T.P., Abou El Hassan M.A., Giaccone G., Kruyt F.A. TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib. Mol. Cancer Ther. 2007, 6:2103-2112.
61. Chauhan D., Singh A., Brahmandam M., Podar K., Hideshima T., Richardson P., Munshi N., Palladino M.A., Anderson K.C. Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma. Blood 2008, 111:1654-1664.
62. Casciano I., Banelli B., Croce M., De Ambrosis A., di Vinci A., Gelvi I., Pagnan G., Brignole C., Allemanni G., Ferrini S., Ponzoni M., Romani M. Caspase-8 gene expression in neuroblastoma. Ann. NY Acad. Sci. 2004, 1028:157-167.
63. Raguenez G., Muhlethaler-Mottet A., Meier R., Duros C., Benard J., Gross N. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. BMC Cancer 2009, 9:97.
64. Kalli K.R., Devine K.E., Cabot M.C., Arnt C.R., Heldebrant M.P., Svingen P.A., Erlichman C., Hartmann L.C., Conover C.A., Kaufmann S.H. Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines. Mol. Pharmacol. 2003, 64:1434-1443.
65. Fulda S., Debatin K.M. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 2002, 21:2295-2308.
66. Shikama Y., Yamada M., Miyashita T. Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases. Eur. J. Immunol. 2003, 33:1998-2006.
67. Arechiga A.F., Bell B.D., Solomon J.C., Chu I.H., Dubois C.L., Hall B.E., George T.C., Coder D.M., Walsh C.M. Cutting edge: FADD is not required for antigen receptor-mediated NF-kappaB activation. J. Immunol. 2005, 175:7800-7804.
68. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., Luhrs K.A., Morrissette N.S., Walsh C.M. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. USA 2008, 105:16677-16682.
69. Han J., Hou W., Goldstein L.A., Lu C., Stolz D.B., Yin X.M., Rabinowich H. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J. Biol. Chem. 2008, 283:19665-19677.
70. Barbero S., Mielgo A., Torres V., Teitz T., Shields D.J., Mikolon D., Bogyo M., Barila D., Lahti J.M., Schlaepfer D., Stupack D.G. Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis. Cancer Res. 2009, 69:3755-3763.
71. Jia S.H., Parodo J., Kapus A., Rotstein O.D., Marshall J.C. Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8. J. Biol. Chem. 2008, 283:5402-5413.
72. S. Barbero, D. Barila, A. Mielgo, V. Stagni, K. Clair, D. Stupack, Identification of a critical tyrosine residue in caspase 8 that promotes cell migration, J Biol Chem., 2008.
73. Finlay D., Howes A., Vuori K. Critical role for caspase-8 in epidermal growth factor signaling. Cancer Res. 2009, 69:5023-5029.
74. Senft J., Helfer B., Frisch S.M. Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res. 2007, 67:11505-11509.
75. Helfer B., Boswell B.C., Finlay D., Cipres A., Vuori K., Bong Kang T., Wallach D., Dorfleutner A., Lahti J.M., Flynn D.C., Frisch S.M. Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res. 2006, 66:4273-4278.
76. Torres V.A., Mielgo A., Barbero S., Hsiao R., Wilkins J.A., Stupack D.G. Rab5 mediates caspase-8-promoted cell motility and metastasis. Mol. Biol. Cell 2010, 21:369-376.